$10.35
0.020.19%
Últ. Act.: Oct 27, 4:15 PM
Core Laboratories (CLB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Core Laboratories (CLB) emitió su última guía sobre julio 29, 2026 para Q3 2026. La compañía estimó unas ganancias por acción en el rango de $0.12 - $0.2, en comparación con una estimación de consenso de EPS de $0.17. Core Laboratories también estimó unos ingresos en el rango de $128.5M - $135.5M para el período.
En comparación con la previsión anterior, Core Laboratories elevado redujo su previsión de ingresos desde un rango anterior de $123M - $131M.
Core Laboratories ha emitido 16 actualizaciones de orientación entre el febrero 1, 2023 y el julio 29, 2026. During this period, the company raised its outlook 6 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.16 | $0.09 | $0.10 | $0.19 |
| Actual | — | $0.11 | $0.06 | $0.21 |
| Surprise | — | +22.2% | -40.0% | +10.5% |
| Revenue | ||||
| Estimate | $131.9M | $126.8M | $124.5M | $131.2M |
| Actual | — | $124.6M | $121.8M | $138.3M |
| Surprise | — | -1.74% | -2.20% | +5.41% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $0.19 | $0.11 | $0.27 |
| Revenue | |||
| Consensus | $134.2M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $0.11 | $0.09 | 22.2 % |
| Q1 | Apr 29, 2026 | $0.06 | $0.10 | -40.0 % |
| Q4 | Feb 4, 2026 | $0.21 | $0.19 | 10.5 % |
| Q3 | Oct 22, 2025 | $0.22 | $0.19 | 15.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $124.61M | $126.81M | -1.74 % |
| Q1 | Apr 29, 2026 | $121.80M | $124.54M | -2.20 % |
| Q4 | Feb 4, 2026 | $138.26M | $131.15M | 5.41 % |
| Q3 | Oct 22, 2025 | $134.52M | $129.78M | 3.65 % |